Evidence map›Paper›PMID 38714679›Full record

ArticleNature communications2024

A comprehensive genetic map of cytokine responses in Lyme borreliosis.

Javier Botey-Bataller, Hedwig D Vrijmoeth, Jeanine Ursinus, Bart-Jan Kullberg, Cees C van den Wijngaard, Hadewych Ter Hofstede, Ahmed Alaswad, Manoj K Gupta, Lennart M Roesner, Jochen Huehn and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Glycolytic reprogramming in host response toExperimental and therapeutic medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Multi-omics Data Integration.Advances in experimental medicine and biology · 2026
    Review
  7. Article
  8. Perinatal transmission ofFrontiers in medicine · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Javier Botey-Bataller *Department of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-3512-3150
Hedwig D Vrijmoeth *Department of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0001-9459-4089
Jeanine UrsinusNational Institute for Public Health and Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands.
Bart-Jan KullbergDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.
Cees C van den WijngaardNational Institute for Public Health and Environment (RIVM), Center for Infectious Disease Control, Bilthoven, the Netherlands.
Hadewych Ter HofstedeDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.
Ahmed AlaswadDepartment of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.
Manoj K GuptaDepartment of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.
Lennart M RoesnerCluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-6651-0458
Jochen HuehnCluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-8071-1379
Thomas WerfelCluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
Thomas F SchulzCluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-8792-5345
Cheng-Jian XuDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.
Mihai G NeteaDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-2421-6052
Joppe W HoviusDepartment of Internal Medicine, Division of Infectious Diseases & Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Leo A B JoostenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0001-6166-9830
Yang LiDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases, Radboud university medical center, Nijmegen, the Netherlands. Yang.Li@helmholtz-hzi.de.ORCID http://orcid.org/0000-0003-4022-7341

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 948207
6 · The paper itself

Abstract

The incidence of Lyme borreliosis has risen, accompanied by persistent symptoms. The innate immune system and related cytokines are crucial in the host response and symptom development. We characterized cytokine production capacity before and after antibiotic treatment in 1,060 Lyme borreliosis patients. We observed a negative correlation between antibody production and IL-10 responses, as well as increased IL-1Ra responses in patients with disseminated disease. Genome-wide mapping the cytokine production allowed us to identify 34 cytokine quantitative trait loci (cQTLs), with 31 novel ones. We pinpointed the causal variant at the TLR1-6-10 locus and validated the regulation of IL-1Ra responses at transcritpome level using an independent cohort. We found that cQTLs contribute to Lyme borreliosis susceptibility and are relevant to other immune-mediated diseases. Our findings improve the understanding of cytokine responses in Lyme borreliosis and provide a genetic map of immune function as an expanded resource.

Indexed as

CytokinesLyme DiseaseQuantitative Trait LociAdultAgedAnti-Bacterial AgentsBorrelia burgdorferiFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansInterleukin-10Interleukin 1 Receptor Antagonist ProteinMaleMiddle AgedPolymorphism, Single NucleotideAnti-Bacterial AgentsCytokinesIL10 protein, humanInterleukin-10Interleukin 1 Receptor Antagonist Protein

Identifiers

PMID38714679
PMCPMC11076587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.